News

The U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of…
Read More...

Takeda Pharmaceutical Company Limited announced that the Ministry of Health, Labour and Welfare (MHLW) granted special approval under article 14-3 of the Pharmaceuticals and Medical…
Read More...

AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18…
Read More...

Sorrento Therapeutics, Inc. announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed with a Phase 2 Pivotal clinical trial of COVI-MSC™, an injectable…
Read More...

GlaxoSmithKline has agreed with Innoviva, Inc (“Innoviva”) - a royalty management company - to sell all of its approximately 32 million shares of common stock of Innoviva back to…
Read More...

Arecor Limited the biopharmaceutical company advancing therapies to enable healthier lives,  announces that it has signed a formulation study partnership with Eli Lilly and Company…
Read More...

Pfizer Inc. and BioNTech SE announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the European Union…
Read More...

Thermo Fisher Scientific Inc. the world leader in serving science, and the University of California, San Francisco (UCSF) announced they have formed a strategic alliance to accelerate…
Read More...

Labcorp announced the expansion of its drug development offering in the Asia-Pacific region with the addition of bioanalytical services in Singapore. “Singapore is a crucial region…
Read More...

Veru Inc. an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, announced that it has enrolled the first…
Read More...

Today, Mandos, LLC (Mandos) announced they have entered into an agreement with Vtesse, LLC, a wholly owned subsidiary of Mallinckrodt Pharmaceuticals (Mallinckrodt), a global…
Read More...

Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company.…
Read More...

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced that it has agreed to make a controlling investment in Mirus Bio, an innovator and…
Read More...

Bristol-Myers Squibb Company and Agenus Inc. announced that they have entered into a definitive agreement under which Bristol Myers Squibb will be granted a global exclusive license to…
Read More...

Sandoz, a Novartis division, announces plans to further strengthen its European antibiotics manufacturing network by further expanding production capabilities in Kundl, Austria and in…
Read More...

CytoDyn Inc. a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced it…
Read More...

Prestige BioPharma Limited (PBP) and Busan City Government announced that the two organisations have entered into a memorandum of understanding (MOU) for the establishment of Research…
Read More...

BioMed X announced the extension of its ongoing collaboration with Merck. Under the new agreement, Merck will start up to six additional research projects at the BioMed X Institute,…
Read More...

InnoCare a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced that China National Medical Products Administration has approved the Phase I clinical…
Read More...

PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer…
Read More...